Oryzon Genomics Eulerpool Vijesti

Oryzon Genomics Eulerpool News

Oryzon Genomics Aktie News

Oryzon Genomics prate mnogi novinari i investitori širom svijeta. Najnovije Oryzon Genomics vijesti prikupljamo ovdje.

• 3. rujna ·

  Yahoo
  ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional “Decision to Grant” Communications
• 29. kolovoza ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in September
• 31. srpnja ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8. srpnja ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28. lipnja ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26. lipnja ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14. lipnja ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3. lipnja ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• 30. svibnja ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• 29. svibnja ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)